The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dioralyte Citrus Powder for Oral Solution

Opella Healthcare France SAS T/A SanofiPA23180/006/002

Main Information

Trade NameDioralyte Citrus Powder for Oral Solution
Active SubstancesGlucose
Sodium chloride
Disodium hydrogen citrate
Potassium chloride
Dosage FormPowder for oral solution
Licence HolderOpella Healthcare France SAS T/A Sanofi
Licence NumberPA23180/006/002

Group Information

ATC CodeA07CA Oral rehydration salt formulations


License statusAuthorised
Licence Issued03/06/1992
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back